IRCT20220211053992N5招募中未知
In vivo Bioequivalence study of Atomoxetine 40 mg capsule manufactured by Pursina Pharmaceutical Co. Compared to innovator Product
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney diseases)
- •Age between 18 to 60 years
排除标准
- •History of cardiovascular, liver, and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
1 期
Y139603 Bioequivalence Study Comparing Atomoxetine Oral Solution and Capsule Formulation in Healthy Adult Male Japanese SubjectsAttention Deficit Hyperactivity DisorderJPRN-jRCT1080221208Eli Lilly Japan K.K.
招募中
2 期
Effectiveness of Atomoxetine treatment for methamphetamine use disorderOther stimulants dependence syndrome.Dependence syndrome: A cluster of behavioral, cognitive, and physiological phenomena that develop after repeated substance use and that typically include a strong desire to take the drug, difficulties in controlling its use, persisting in its use despiteF15.24IRCT2017070234844N1Tehran University of Medical Sciences (TUMS), Vice-chancellor for Research90
招募中
2 期
Study of the effect of Atomoxetine on cognitive symptoms in patients with schizophreniaIRCT20101130005280N31Mashhad University of Medical Sciences42
招募中
不适用
Test7 Cold Pills tablet (Acetaminophen / Phenylephrine / Chlorpheniramine / Dextromethorphan 500/2/15 / 15mg )n-vivo Bioequivalence study in Iranian healthy volunteers.IRCT20200105046010N3Tabriz University of Medical Sciences24
招募中
不适用
In-vivo Bioequivalence Test of Dapoxetine tablet 30 mg Mofid Pharma with brand drug (PRILIGY® 30 mg Tab, Menarini, Italy)IRCT20200105046010N64Teb Mofid Nikan Pharmaceutical Co.24